XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF INCOME (LOSS) (UNAUDITED) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue        
Rentals of medical equipment $ 23,228,000 $ 23,531,000 $ 71,578,000 $ 72,804,000
Sales of medical equipment and supplies 35,061,000 37,228,000 105,468,000 111,779,000
Total revenue 58,289,000 60,759,000 177,046,000 184,583,000
Cost of inventory sold 14,873,000 16,694,000 47,776,000 51,260,000
Operating expenses 31,041,000 30,593,000 91,333,000 91,096,000
Depreciation 9,758,000 9,573,000 29,061,000 28,474,000
Amortization of intangible assets 1,481,000 1,519,000 4,548,000 4,570,000
Right-of-use operating lease amortization and interest 1,585,000 1,660,000 4,753,000 4,612,000
Stock-based compensation 2,120,000 483,000 2,625,000 2,154,000
Acquisition-related costs 126,000 188,000 222,000 393,000
Gain on disposals of property and equipment (872,000) (51,000) (896,000) (51,000)
Operating income (loss) (1,823,000) 100,000 (2,376,000) 2,075,000
Interest expense 1,595,000 1,770,000 5,025,000 5,366,000
Interest income (101,000) (168,000) (383,000) (509,000)
Change in fair value of derivative liability - interest rate swaps 182,000 (105,000) (442,000) 170,000
Loss (gain) on foreign currency transactions (610,000) 128,000 231,000 145,000
Share of loss in equity method investment 101,000 71,000 245,000 243,000
Loss before taxes (2,990,000) (1,596,000) (7,052,000) (3,340,000)
Provision for income taxes 35,000 0 99,000 483,000
Net loss $ (3,025,000) $ (1,596,000) $ (7,151,000) $ (3,823,000)
Net loss per share        
Basic loss per share $ (0.07) $ (0.04) $ (0.17) $ (0.09)
Diluted loss per share $ (0.07) $ (0.04) $ (0.17) $ (0.09)
Weighted average number of common shares outstanding:        
Basic (in shares) 43,459 42,623 43,240 42,303
Diluted (in shares) 43,459 42,623 43,240 42,303